NFKB1 and breast carcinoma: In particular, IKKε was shown to induce breast cancer via mechanisms involving CYLD (Hutti et al, 2009) and TRAF2 (Zhou et al, 2013), ultimately mediating NFκB activation (Boehm et al, 2007).